Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Circulatory system devices panel

This article was originally published in The Gray Sheet

Executive Summary

Public meeting will be held April 12-14 in Washington, D.C. The panel will discuss premarket applications for implantable cardioverter defibrillators, prosthetic cardiac valves and interventional cardiology devices. Lilly's Cardiac Pacemakers, Inc. subsidiary says that its Endotak transvenous cardioverter defibrillator lead system is scheduled to be reviewed at the meeting. For further information contact Wolf Sapirstein at 301/427-1205.



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts